Chronic pain management in dermatology : Pharmacotherapy and therapeutic monitoring with opioid analgesia - 14/09/15
Abstract |
A number of chronic dermatologic conditions may necessitate long-term adjunctive pain management in addition to treatment of the primary skin disease, such as hidradenitis suppurativa, lichen planus, and other systemic diseases associated with significant pain. Adequate management of chronic pain can represent a unique challenge, but remains an integral component of clinical treatment in relevant contexts. For nociceptive pain of moderate to severe intensity, opioid analgesics can be beneficial when other pain management strategies have failed to produce adequate relief. The decision to initiate long-term opioid therapy must be carefully weighed, and individualized treatment plans are often necessary to effectively treat pain while minimizing adverse effects. Part II of this 2-part continuing medical education article will describe the appropriate settings for initiation of opioid analgesia for dermatology patients and detail therapeutic strategies and patient monitoring guidelines.
Le texte complet de cet article est disponible en PDF.Key words : nonsteroidal antiinflammatory drugs, opioid analgesia, pain, postherpetic neuralgia
Abbreviations used : FDA, NSAID
Plan
Funding sources: None. |
|
Dr Kimball is an investigator for and consultant to Abbvie. Dr Rathmell and Dr Enamandram have no conflicts of interest to declare. |
|
Date of release: October 2015 |
|
Expiration date: October 2018 |
Vol 73 - N° 4
P. 575-582 - octobre 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?